JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2024, 73(3):148-155 | DOI: 10.36290/csf.2024.023

Pharmaceutical care for patients with acne

Tereza Toušková, Kateřina Malá-Ládová
Katedra sociální a klinické farmacie, Farmaceutická fakulta UK v Hradci Králové

Acne is a multifactorial inflammatory skin disease affecting mostly adolescents, but it can persist into adulthood. The aim of treatment is to improve the patient's dermatological condition and improve the overall quality of life. Pharmacists play a very important role in the care of acne patients and this article reviews opportunities for pharmaceutical care of such patients. Pharmacists can identify patients with different forms of acne, engage in acne prevention including lifestyle modifications, and contribute to optimizing the choice and use of appropriate pharmacotherapy accompanied by non-pharmacological approaches according to the specific patient characteristics. The mainstay of acne treatment is topical pharmacotherapy, where over-the-counter products containing benzoyl peroxide or azelaic acid may be recommended for mild to moderate forms of acne. Retinoids or their combination with antibiotics are prescribed for moderate and severe forms of acne. When topical treatment is ineffective or resistant, systemic treatment including for example oral antibiotics or isotretinoin is considered. Pharmacists thus engage themselves in maximizing the effect and minimizing the risks of these drugs and, last but not least, educating patients on how to properly care for their skin using so called dermocosmetics, which is defined in this article.

Keywords: acne, cosmetic products, dermocosmetics, pharmaceutical care, topical treatment, system treatment, pharmacy.

Accepted: September 23, 2024; Published: October 8, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Toušková T, Malá-Ládová K. Pharmaceutical care for patients with acne. Čes. slov. farm. 2024;73(3):148-155. doi: 10.36290/csf.2024.023.
Download citation
PDF will be unlocked 8.10.2025

References

  1. Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. Jama. 2021;326(20):2055-2067. Go to original source... Go to PubMed...
  2. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2024;90(5):1006-e1. Go to original source... Go to PubMed...
  3. Obstová I. Etiopatogeneze a terapie acne vulgaris. Dermatol Pro Praxi. [Internet]. 2015;9(3):111-115.
  4. Gollnick H, Zouboulis CC. Acne vulgaris: Overview of management. In: UpToDate. 2024. Available from https://www.uptodate.com/contents/acne-vulgaris-overview-of-management.
  5. Shen YC, Chiu WK, Kang YN, et al. Microneedling monotherapy for acne scar: systematic review and meta-analysis of randomized controlled trials. Aesthetic Plastic Surgery. 2022;46(4):1913-1922. Go to original source... Go to PubMed...
  6. Dalgard F, Gieler U, Holm J, et al. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. Journal of the American Academy of Dermatology. 2008;59(5):746-751. Go to original source... Go to PubMed...
  7. Whittlesea C, Hodson K. (Eds.). Clinical Pharmacy and Therapeutics E-Book: Clinical Pharmacy and Therapeutics E-Book. Elsevier Health Sciences. 2018.
  8. França K. Topical probiotics in dermatological therapy and skincare: a concise review. Dermatology and therapy. 2021;11(1):71-77. Go to original source... Go to PubMed...
  9. Pavelková M. Mastná pleť a akné - co doporučit v lékárně? Dermatol Praxi. 2022;18(3):170-174. Go to original source...
  10. Podgorska A, Puścion-Jakubik A, Markiewicz-Żukowska R, et al. Acne vulgaris and intake of selected dietary nutrients - a summary of information. In Healthcare. 2021;9(6):668. Go to original source... Go to PubMed...
  11. Kent DM, Steyerberg E, Van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. Bmj. 2018: 363. Go to original source... Go to PubMed...
  12. Mitchell BL, Saklatvala JR, Dand N, et al. Genome-wide association meta-analysis identifies 29 new acne susceptibility loci. Nature communications. 2022;13(1);702. Go to original source... Go to PubMed...
  13. Fagron Genomics. AcneTest - DNA analýza pro léčbu akné na míru pacienta. Available from https://www.fagron-genomics.cz/ancetest-dna-analyza-pro-lecbu-akne-na-miru-pacienta.
  14. Vantuchová MY. Lokální léčba akné. Dermatol Pro Praxi. 2014;8(4):140-143.
  15. Státní ústav pro kontrolu léčiv. Databáze léků. Available from https://www.sukl.cz/modules/medication/search.php.
  16. Dallo M, Patel K, Hebert AA. Topical antibiotic treatment in dermatology. Antibiotics. 2023;12(2):188. Go to original source... Go to PubMed...
  17. Státní ústav pro kontrolu léčiv. Skinoren krém: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0022032.
  18. Nevoralová Z. Nežádoucí účinky léčby akné a jejich řešení. Dermatol Pro Praxi. 2021;15(1):19-27. Go to original source...
  19. Státní ústav pro kontrolu léčiv. Akneroxid: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/download.php?file=SPC175003.pdf & type=spc & as=akneroxid-spc.
  20. Macháčková MK. Lokální léčba akné vulgaris. Dermatol Pro Praxi. 2018;12(2):78-80. Go to original source...
  21. Chien AL, Qi J, Rainer B, Sachs, et al. Treatment of acne in pregnancy. The Journal of the American Board of Family Medicine. 2016;29(2):254-262. Go to original source... Go to PubMed...
  22. Nevoralová MZ. Udržovací léčba akné. Dermatol Pro Praxi. 2016;10(1):10-15. Go to original source...
  23. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. The Journal of clinical and aesthetic dermatology 2011;4(2): 40.
  24. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. Journal of the American Academy of Dermatology. 2009;60(5):S1-S50. Go to original source... Go to PubMed...
  25. Státní ústav pro kontrolu léčiv. Deoxymykoin: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices
  26. Greenberger NJ. Absorption of tetracyclines: interference by iron. Annals of Internal Medicine. 1971;74(5):792-793. Go to original source... Go to PubMed...
  27. Státní ústav pro kontrolu léčiv. Azitrox, Sumamed: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices
  28. Hrouzková MA. Současné přístupy k léčbě papulopustulózní akné. Dermatologie pro praxi. 2016;10(3):112-116. Go to original source...
  29. Mavranezouli I, Daly CH, Welton NJ, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022;187(5):639-649. Go to original source... Go to PubMed...
  30. Státní ústav pro kontrolu léčiv. Dalacin C: Souhrn údajů o přípravku (SPC). Dostupné z: https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices
  31. National Institute for Health and Care Excellence (NICE). Management of acne vulgaris: summary of NICE guidance. BMJ. 2021;374:n1800. Go to original source... Go to PubMed...
  32. Státní ústav pro kontrolu léčiv. Aknenormin, Curakné: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices.
  33. Rulcová J, Nevoralová Z, Benáková N. Obličejové dermatózy. Mladá fronta. 2016.
  34. Allen RH Combined estrogen-progestin oral contraceptives: patient selection, counseling, and use. UpToDate, Waltham, MA. 2022. Available from https://www.uptodate.com/contents/combined-estrogen-progestin-oral-contraceptives-patient-selection-counseling-and-use.
  35. DermNet. Anti-androgen therapy: Hormonal treatment for acne and hirsutism. 2023. Available from https://dermnetnz.org/topics/anti-androgen-therapy.
  36. Zákon č. 258/2000 Sb., o ochraně veřejného zdraví a o změně některých souvisejících zákonů. Available from https://www.zakonyprolidi.cz/cs/2000-258.
  37. Nařízení Evropského parlamentu a Rady (ES) č. 1223/2009 ze dne 30. listopadu 2009 o kosmetických přípravcích. Available from https://eur-lex.europa.eu/legal-content/CS/TXT/?uri=CELEX%3A32009R1223.
  38. Nařízení Komise (EU) č. 655/2013 ze dne 10. července 2013, kterým se stanoví společná kritéria pro zdůvodnění tvrzení používaných ve vztahu ke kosmetickým výrobkům. Available from https://eur-lex.europa.eu/legal-content/CS/TXT/?uri=CELEX%3A32013R0655
  39. Tan J, Bhate K, Hoeger PH, et al. The role and benefits of dermocosmetics in acne management in Japan. Dermatol Ther (Heidelb). 2023;13(7):1423-1433. Go to original source... Go to PubMed...
  40. Araviiskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30(6):926-935. Go to original source... Go to PubMed...
  41. Saint-Leger D. Cosmeceuticals. Of men, science and laws. Int J Cosmet Sci. 2012;34(5):396-401. Go to original source... Go to PubMed...
  42. Schäfer N, Sobczyk M, Burczyk D, et al. Possibilities of using vegetable oils in acne skin care. Aesth Cosmetol Med. 2022;11(2):49-54. Go to original source...
  43. Kovács A, Péter-Héderi D, Perei K, et al. Effects of formulation excipients on skin barrier function in creams used in pediatric care. Pharmaceutics. 2020;12(729):1-15. Go to original source... Go to PubMed...
  44. Nevoralová MZ. Úloha dermokosmetiky v léčbě akné. Dermatol Pro Praxi. 2020;14(1):23-27. Go to original source...
  45. Araviiskaia E, Lopez Estebaranz JL, Pincelli C. Dermocosmetics: Beneficial adjuncts in the treatment of acne vulgaris. J Dermatolog Treat. 2021;32(1):3-10. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.